Torthaí cuardaigh - Po‐Ren Hsueh
- 1 - 20 toradh as 168 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
-
2
Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV de réir Ping‐Ing Lee, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2020Artigo -
3
Old and re-purposed drugs for the treatment of COVID-19 de réir Shio-Shin Jean, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2020Revisão -
4
Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19 de réir Ping‐Ing Lee, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2023Revisão -
5
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter... de réir Y.-T. Lee, S.-M. Tsao, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2013Artigo -
6
Guidelines on Blood Cultures de réir Michael Towns, William R. Jarvis, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2010Artigo -
7
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria de réir Shio-Shin Jean, Dorji Harnod, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2022Revisão -
8
-
9
Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections de réir Yen‐Hsu Chen, Wen‐Chien Ko, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2013Revisão -
10
Current Status of Antimicrobial Resistance in Taiwan de réir Po‐Ren Hsueh, Cheng-Yi Liu, Kwen‐Tay Luh
Foilsithe / Cruthaithe 2002Artigo -
11
-
12
-
13
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms de réir Nan–Yao Lee, Wen‐Chien Ko, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2019Revisão -
14
Treatment options for COVID-19: The reality and challenges de réir Shio-Shin Jean, Ping‐Ing Lee, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2020Revisão -
15
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? de réir Chih-Cheng Lai, Cheng‐Yi Wang, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2020Revisão -
16
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review de réir Chih-Cheng Lai, Jui-Hsiang Wang, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2020Revisão -
17
Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials de réir Chih‐Cheng Lai, Chien‐Ming Chao, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2021Revisão -
18
-
19
Utility of Metagenomic Next-Generation Sequencing for Etiological Diagnosis of Patients with Sepsis in Intensive Care Units de réir Jung‐Yien Chien, Chong‐Jen Yu, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2022Artigo -
20
Geographic patterns of Acinetobacter baumannii and carbapenem resistance in the Asia-Pacific Region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) prog... de réir Yu-Lin Lee, Wen‐Chien Ko, Po‐Ren Hsueh
Foilsithe / Cruthaithe 2022Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Medicine
Microbiology
Antibiotics
Internal medicine
Genetics
Bacteria
Gene
Antibiotic resistance
Disease
Virology
Pseudomonas aeruginosa
Pathology
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Imipenem
Biochemistry
Bacteremia
Escherichia coli
Antimicrobial
Immunology
Intensive care medicine
Pneumonia
Staphylococcus aureus
Acinetobacter baumannii
Klebsiella pneumoniae
Surgery
Tuberculosis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Drug resistance